期刊文献+

听神经瘤临床特征与肿瘤细胞增殖因子的相关性研究 被引量:2

Relevance between clinical behavior and bionomical findings of acoustic neuromas
原文传递
导出
摘要 目的探讨肿瘤增殖标记指数(labeling index,LI)Ki-67、增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)、转移生长因子-β1(transforming growth factor-β1,TGF-β1)在听神经瘤组织标本中表达的意义及其与临床行为之间的相关性。方法回顾性分析听神经瘤手术患者53例的临床资料,对其石蜡切片病理标本进行Ki-67、PCNA和TGF-β1免疫组化学常规步骤染色。用SAS9.0统计软件包进行统计分析。结果53例中,Ki-67阳性率77.4%(41/53),PCNA阳性率84.9%(45/53);Ki-67阳性与病程和临床生长率有关(t=2.14和2.70,P值均〈0.05);PCNA阳性与临床生长率有关(t'=-4.45,P〈0.05);TGF-β1阳性表达83.0%(44/53),与Ki-67增殖标记指数呈正相关(r=0.36,P〈0.05)。53例中囊性变者比非囊变者肿瘤直径明显增大(Z=4.44,P〈0.05);囊性变者与非囊变者,其肿瘤增殖标记指数Ki-67、PCNA、TGF-β1和病程之间无相关性。听神经瘤囊性变者比非囊变者临床生长率增大,但差异无统计学意义。结论Ki-67和PCNA与肿瘤的细胞增殖有关,增殖指数与临床生长率有关。双向调节因子TGF-β1参与了听神经瘤的生物学行为。囊性变听神经瘤,其增长与肿瘤的增殖活性关系不大,其增长是囊的容积增加,而非肿瘤细胞生长速度的加快。 Objective To evaluate the relationship between labeling index(LI) Ki-67, proliferating cell nuclear antigen ( PCNA ) and transforming growth factor-β1 ( TGF-β1 ) with the clinical behavior of acoustic neuroma. Methods Expression of Ki-67, PCNA and TGF-β1 was detected by immunohistochemistry in 53 specimens of acoustic neuromas. The relationship among tumor proliferation, histological representation, size of tumor, clinical proliferation index of tumor and tumor proliferation activity were analyzed. Results In all 53 cases, the positive rate of Ki-67 was 77.4% (41/53) but the positive rate of PCNA was 84.9% (45/53). There was significant difference between the proliferate index, clinic growth rate and course of disease(t =2. 14, t =2. 70; P 〈0. 05). The positive rate of TGF-β1 was 83. 0% (44/53). The correlation of TGF-β1 with LI( Ki-67 ) was significant difference (r = 0. 36 ,P 〈 0. 05 ). Cystic degeneration often occurred in large-size tumor (Z = 4. 44 ,P 〈 0.05 ). There was no significant relationship between the expression of LI( Ki-67 ), LI(PCNA) and TGF-β1 and the course of disease as well as between the cystic degeneration and the non-cystic degeneration. Although clinic growth rate of cystic degeneration was bigger than that of non-cystic degeneration, there was not statistically significant. Conclusions Ki-67 and PCNA are reflected proliferation activities of tumor cells in acoustic neuromas. Cell proliferation-labeling index LI( PCNA)was related with clinical growth rates. TGF-β1 might participate in the biological behavior of acoustic neuroma. Cystic degeneration was one of special pattern of acoustic neuroma, however, tumor enlargement might due to the volume of the cystic but unrelate to fast proliferation of parenchyma cell.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2008年第2期125-129,共5页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
关键词 神经瘤 KI-67抗原 增殖细胞核抗原 转化生长因子Β Neuromas, acoustic Ki-67 antigen Proliferating cell nuclear antigen Transforming growth factor beta
  • 相关文献

参考文献17

  • 1Cardillo MR, Filipo R, Monini S, et al. Transforming growth factorβ1 expression in human acoustic neuroma. Am J Otol, 1999,20 : 65-68.
  • 2Bedavanija A, Brieger J, Lehr HR, et al. Association of proliferative activity and size in acoustic neuroma: implications for timing of surgery. J Neurosurg,2003 , 98 :807-811.
  • 3Takeuchi H, Kubota T, Kabuto M, et al. Prediction of recurrence in histologicaUy benign meningiomas:proliferafing cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol, 1997,48: 501-506.
  • 4Kawarnoto Y, Uozumi T, Kiya K, et al. Clinicopathologic growth factors of acoustic neuromas. Surg Neurol, 1995,43:546-552.
  • 5罗其中,卞留贯,沈建康,邱永明,王勇.听神经瘤的临床特征与其细胞增殖之间的相关性[J].中华神经外科杂志,2000,16(1):32-34. 被引量:15
  • 6Wiet R J, Ruby SG, Bauer GP. Proliferating cell nuclear antigen in the determination of growth rates in acoustic neuromas Am J Otol, 1994,15:294-298.
  • 7Herwadker A, Vokurka EA, Evans DG, et al. Size and growth rate of sporadic vestibular schwannoma: predictive value of information available at presentation. Otol Neurotol, 2005,26:86-92.
  • 8Mohyuddin A, Vokurka EA, Evans DG, et al. Is clinical growth index a reliable predictor of tumour growth in vestibular schwannomas? Clin Otolaryngol Allied Sci, 2003,28:855.
  • 9Raut VV, Walsh RM, Bath AP, et al. Conservative management of vestibular schwannomas-second review of a prospective longitudinal study. Clin Otolaryngol Allied Sci,2004,29:505-514.
  • 10Charabi S, Engel P, Charabi B, et al. Growth of vestibular schwannomas: in situ model employing the monoantibody Ki-67 and DNA flow cytometry. Am J Otol, 1996,17:301-306.

二级参考文献9

  • 1卞留贯,国外医学.神经病学、神经外科分册,1998年,25卷,124页
  • 2Cardillo MR, Filipo R, Monini S, et al. Transforming growth factor-betal expression in human acoustic neuroma[J]. Am J Otol, 1999, 20( 1 ): 65-68.
  • 3Irving RM, Moffat DA, Hardy DG, et al. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma [ J]. Hum Mol Genet,1994,3(2) :347-350.
  • 4Mathews MB, Bernstein RM, Franza BR, et al. Identity of the proliferating cell nuclear antigen and cyclin [ J ]. Nature, 1984,309 (5966): 374-376.
  • 5Morris GF, Mathews MB. Regulation of proliferating cell nuclear antigen during the cell cycle[J]. J Biol Chem, 1989,264(23) :13856-13864.
  • 6Massague J. The transforming growth factor-beta family[J]. Annu Rev Cell Biol, 1990,6:597-641.
  • 7Wiet RJ, Ruby SG, Bauer GP. Proliferating cell nuclear antigen in the determination of growth rates in acoustic neuromas[J]. Am J Otol, 1994,15(3) :294-298.
  • 8卞留贯.NF2肿瘤抑制基因与中枢神经系统良性肿瘤[J].国外医学(神经病学.神经外科学分册),1998,25(3):124-127. 被引量:15
  • 9罗其中,卞留贯,沈建康,邱永明,王勇.听神经瘤的临床特征与其细胞增殖之间的相关性[J].中华神经外科杂志,2000,16(1):32-34. 被引量:15

共引文献14

同被引文献37

  • 1李洛,孟庆海,雷霆,鲍文公.bFGF及TPK抑制剂对听神经瘤细胞增殖的影响[J].山东医药,2004,44(30):4-6. 被引量:1
  • 2张玉海,鲍文公,付海霞,潘顺.GGF及Ki67表达与听神经瘤细胞增殖相关性的探讨[J].中国肿瘤临床,2004,31(8):452-455. 被引量:4
  • 3Utermark T,Kaempchen K,Hanemann CO.Pathological adhesion of primary human Schwannoma cells is dependent on altered expression of integrins[J].Brain Pathol,2003,13:352.
  • 4Burden S,Yarden Y.Neuregulins and their receptors:a versatile signaling module in organogenesis and oncogenesis[J].Neuron,1997,18:847.
  • 5Salzer JL,Bunge RP.Studies of Schwann cell proliferation.I.Ananalysis in tissue culture of proliferation during development,Wallerian degeneration,and direct injury[J].Cell Biol,1980,84:739.
  • 6Jessen KR,Mirsky R.Origin and early development of Schwann cells.Microsc[J].Res Tech,1998,41:393.
  • 7Adlkofer K,Lai C.Role of neuregulins in glial cell development[J].Gila,2000,29:104.
  • 8Zanazzi G,Einheber S,Westreich R,et al.Glial growth factor/neuregulin inhibits Schwann cell myelination and Induces demyelination[J].The Journal of Cell Biology,2001,152:1 289.
  • 9Sherman LS,Rizvi TA,Karyala S,et al.CD44 enhances neuregulin signaling by Schwann cells[J].The Journal of Cell Biology,20000150:1 071.
  • 10Huijbregts RP,Roth KA,Sehmidt RE,et al.Hypertrophic neuropathies and malignant peripheral nerve sheath tumors in transgenic mice overexpressing glial growth Factor -3 in myelinating Schwann cells[J].The Journal of Neuroscience,2003,23:7 269.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部